Quick to Clinic™ Delivers Phase I Clinical Trial Material, Fast

Fact Sheet

The pressure to file an IND makes accelerated Phase I safety testing a priority. With the Quick to Clinic™️ program, Thermo Fisher Scientific can help deliver your large molecule drug substance for First-in-Human studies in as little as 13 months from the start of transfection.

Now you can meet important milestones—such as filing for IND—or secure additional funding with all the confidence your project needs and, we can supply.